Skip to content

Carestream Pacs

by Carestream Health, Inc.

510(k) K110919

Carestream Pacs is a Class II device made by Carestream Health, Inc., cleared under FDA 510(k) K110919 on 20 Oct 2011, active as of 22 Oct 2026. 50 FDA recalls are linked to it.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

1 ongoing

This device is named in the recall

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK110919 Date20 Oct 2011ClearedStatusActive

Official records

Recalls

50 recalls · 1 ongoing · FDA

    • Ongoing Z-0497-2025 FDA Class II initiated 10 Oct 2024

    A software issue affecting Philips Vue PACS may cause incorrect ischemic map and table value calculations when using the export function in the Perfusion Application for a Siemens CT perfusion study, resulting in misdiagnosis due to incorrect ischemic map and table values.

  • 49 recalls, same reason

    • Terminated Z-0246-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0215-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0260-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0230-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0238-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0243-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0236-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0256-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0235-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0254-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0240-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0226-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0249-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0211-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0231-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0255-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0232-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0221-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0212-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0259-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0217-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0223-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0228-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0225-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0224-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0227-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0214-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0241-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0242-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0258-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0257-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0239-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0234-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0248-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0220-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0213-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0245-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0253-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0251-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0233-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0216-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0237-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0252-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0222-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0218-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0229-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0250-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0244-2014 FDA Class II initiated 16 Sep 2013
    • Terminated Z-0219-2014 FDA Class II initiated 16 Sep 2013

    Carestream Health, Inc. has issued a recall when using the CARESTREAM Client Workstation where under very specific conditions, some images from multi-slice studies such as CT and MR may not load into the viewer application due to a software problem.

Timeline

51 dated events

  1. Recall initiated FDA recalls Z-0216-2014
  2. Recall initiated FDA recalls Z-0237-2014
  3. Recall initiated FDA recalls Z-0252-2014
  4. Recall initiated FDA recalls Z-0222-2014
  5. Recall initiated FDA recalls Z-0218-2014
  6. Recall initiated FDA recalls Z-0229-2014
  7. Recall initiated FDA recalls Z-0250-2014
  8. Recall initiated FDA recalls Z-0244-2014
  9. Recall initiated FDA recalls Z-0219-2014
  10. Recall initiated FDA recalls Z-0497-2025

41 earlier events are in the sections above.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
LLZ
Device class
Class II
Regulation
21 CFR Part 892.2050
Advisory committee
Radiology
FDA decision
SESE Substantially Equivalent

Devices cleared under K110919

3 devices · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K110919
UDI-DISize and differences
Vue PACS
CARESTREAM HEALTH, INC.
1149418 / Vue PACS60889971047809 —On the market
Vue PACS
CARESTREAM HEALTH, INC.
1201284 / Vue PACS60889971041692 —On the market
Vue PACS - 12
Philips Medical Systems Nederland B.V.
8986424 / Vue PACS - 1200884838100336 —On the market

Similar devices

Other devices filed under FDA product code LLZ (System, Image Processing, Radiological).

Other devices from Carestream Health, Inc.

See all devices from Carestream Health, Inc. →